-
21
Very first real-world data on zongertinib use in non-small cell lung cancer patients with HER2 mutations: A brief report
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article -
22
The impact of PD-L1 expression status on the prognosis of ALK-positive lung cancer patients
Published 2024-01-01“…Cancer Treatment and Research Communications…”
Get full text
Article